Literature DB >> 34630741

OntoRepliCov: an Ontology-Based Approach for Modeling the SARS-CoV-2 Replication Process.

Wissame Laddada1,2, Lina F Soualmia1, Cecilia Zanni-Merk1, Ali Ayadi2, Claudia Frydman2, India L'Hote3, Isabelle Imbert3.   

Abstract

Understanding the replication machinery of viruses contributes to suggest and try effective antiviral strategies. Exhaustive knowledge about the proteins structure, their function, or their interaction is one of the preconditions for successfully modeling it. In this context, modeling methods based on a formal representation with a high semantic expressiveness would be relevant to extract proteins and their nucleotide or amino acid sequences as an element from the replication process. Consequently, our approach relies on the use of semantic technologies to design the SARS-CoV-2 replication machinery. This provides the ability to infer new knowledge related to each step of the virus replication. More specifically, we developed an ontology-based approach enriched with reasoning process of a complete replication machinery process for SARS-CoV-2. We present in this paper a partial overview of our ontology OntoRepliCov to describe one step of this process, namely, the continuous translation or protein synthesis, through classes, properties, axioms, and SWRL (Semantic Web Rule Language) rules.
© 2021 The Author(s). Published by Elsevier B.V.

Entities:  

Keywords:  Knowledge representation; SWRL; biology domain; reasoning process

Year:  2021        PMID: 34630741      PMCID: PMC8486259          DOI: 10.1016/j.procs.2021.08.050

Source DB:  PubMed          Journal:  Procedia Comput Sci


  14 in total

1.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

Review 2.  Déjà vu: Stimulating open drug discovery for SARS-CoV-2.

Authors:  Sean Ekins; Melina Mottin; Paulo R P S Ramos; Bruna K P Sousa; Bruno Junior Neves; Daniel H Foil; Kimberley M Zorn; Rodolpho C Braga; Megan Coffee; Christopher Southan; Ana C Puhl; Carolina Horta Andrade
Journal:  Drug Discov Today       Date:  2020-04-19       Impact factor: 7.851

3.  Stochastic Modeling and Simulation of Viral Evolution.

Authors:  Luiza Guimarães Fabreti; Diogo Castro; Bruno Gorzoni; Luiz Mario Ramos Janini; Fernando Antoneli
Journal:  Bull Math Biol       Date:  2018-12-14       Impact factor: 1.758

Review 4.  Mathematical modeling of within-host Zika virus dynamics.

Authors:  Katharine Best; Alan S Perelson
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

5.  Modeling and Control for HIV/AIDS Transmission in China Based on Data from 2004 to 2016.

Authors:  Zhiming Li; Zhidong Teng; Hui Miao
Journal:  Comput Math Methods Med       Date:  2017-09-12       Impact factor: 2.238

Review 6.  Approaches Based on Artificial Intelligence and the Internet of Intelligent Things to Prevent the Spread of COVID-19: Scoping Review.

Authors:  Aya Sedky Adly; Afnan Sedky Adly; Mahmoud Sedky Adly
Journal:  J Med Internet Res       Date:  2020-08-10       Impact factor: 5.428

7.  Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.

Authors:  Lopamudra Dey; Sanjay Chakraborty; Anirban Mukhopadhyay
Journal:  Biomed J       Date:  2020-09-03       Impact factor: 4.910

8.  Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models.

Authors:  Michael R Garvin; Erica T Prates; Mirko Pavicic; Piet Jones; B Kirtley Amos; Armin Geiger; Manesh B Shah; Jared Streich; Joao Gabriel Felipe Machado Gazolla; David Kainer; Ashley Cliff; Jonathon Romero; Nathan Keith; James B Brown; Daniel Jacobson
Journal:  Genome Biol       Date:  2020-12-23       Impact factor: 13.583

9.  A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing.

Authors:  David E Gordon; Gwendolyn M Jang; Mehdi Bouhaddou; Jiewei Xu; Kirsten Obernier; Matthew J O'Meara; Jeffrey Z Guo; Danielle L Swaney; Tia A Tummino; Ruth Hüttenhain; Robyn M Kaake; Alicia L Richards; Beril Tutuncuoglu; Helene Foussard; Jyoti Batra; Kelsey Haas; Maya Modak; Minkyu Kim; Paige Haas; Benjamin J Polacco; Hannes Braberg; Jacqueline M Fabius; Manon Eckhardt; Margaret Soucheray; Melanie J Bennett; Merve Cakir; Michael J McGregor; Qiongyu Li; Zun Zar Chi Naing; Yuan Zhou; Shiming Peng; Ilsa T Kirby; James E Melnyk; John S Chorba; Kevin Lou; Shizhong A Dai; Wenqi Shen; Ying Shi; Ziyang Zhang; Inigo Barrio-Hernandez; Danish Memon; Claudia Hernandez-Armenta; Christopher J P Mathy; Tina Perica; Kala B Pilla; Sai J Ganesan; Daniel J Saltzberg; Rakesh Ramachandran; Xi Liu; Sara B Rosenthal; Lorenzo Calviello; Srivats Venkataramanan; Yizhu Lin; Stephanie A Wankowicz; Markus Bohn; Raphael Trenker; Janet M Young; Devin Cavero; Joe Hiatt; Theo Roth; Ujjwal Rathore; Advait Subramanian; Julia Noack; Mathieu Hubert; Ferdinand Roesch; Thomas Vallet; Björn Meyer; Kris M White; Lisa Miorin; David Agard; Michael Emerman; Davide Ruggero; Adolfo García-Sastre; Natalia Jura; Mark von Zastrow; Jack Taunton; Olivier Schwartz; Marco Vignuzzi; Christophe d'Enfert; Shaeri Mukherjee; Matt Jacobson; Harmit S Malik; Danica G Fujimori; Trey Ideker; Charles S Craik; Stephen Floor; James S Fraser; John Gross; Andrej Sali; Tanja Kortemme; Pedro Beltrao; Kevan Shokat; Brian K Shoichet; Nevan J Krogan
Journal:  bioRxiv       Date:  2020-03-22

10.  Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.

Authors:  Vincent Madelain; Sylvain Baize; Frédéric Jacquot; Stéphanie Reynard; Alexandra Fizet; Stephane Barron; Caroline Solas; Bruno Lacarelle; Caroline Carbonnelle; France Mentré; Hervé Raoul; Xavier de Lamballerie; Jérémie Guedj
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.